CD4 and psoriasis: For example, a study by Wu et al. utilised topically applied imiquimod (IMQ), which induces psoriasis-like dermatitis in a murine model [138] and is built upon previous studies that highlighted elevated levels of miR-210 in psoriatic CD4+ T cells and PBMCs of patients with psoriasis in comparison to healthy controls [139].